Lewy body dementia - Clinical, pathological and neurochemical interconnections

Journal of Neural Transmission, Supplement

Volumn , Issue 51, 1997, Pages 95-109

  Perry, R ^a,b   McKeith, I ^a   Perry, E ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; NEUROLEPTIC AGENT;

AGED; AMYLOIDOSIS; CHOLINERGIC ACTIVITY; CLINICAL FEATURE; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG SENSITIVITY; HALLUCINATION; HUMAN; LEWY BODY; NEUROCHEMISTRY; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SENILE DEMENTIA; SYMPTOMATOLOGY; BRAIN LEVEL; DEMENTIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

AGED; BRAIN CHEMISTRY; DEMENTIA; HUMANS; LEWY BODIES;

EID: 0031283211     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6846-2_8     Document Type: Conference Paper

References (33)

1. Ballard CG, Mohan RNC, Patel A, Bannister C (1993) Idiopathic clouding of consciousness - do the patients have cortical Lewy body disease? Int J Geriatr Psychiatry 8: 571-576
2. Buckley NJ, Bonner T, Buckley CM, Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-Ki cells. Mol Pharmacol 35: 469-479
3. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38: 1520-1528
4. Byrne EJ (1995) Cortical Lewy body disease: an alternative view. In: Levy R, Howard R (eds) Developments in dementia and functional disorders in the elderly. Wrightson, London, pp 21-30
5. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB, Jefferson D, Lowe J, Mayer RJ, Landon M, Doherty FJ (1991) Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 2: 283-284
6. Court JA, Perry EK, Johnson M, Piggott MA, Kerwin JM, Perry RH, Ince PG (1993) Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Dev Brain Res 74(1): 73-82
7. Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI (1990) Antemortem diagnosis of diffuse Lewy body disease. Neurology 40: 1523-1528
8. Dickson DW, Davies P, Mayeux R, Crystal H, Haroupian DS, Thompson J, Goldman JE (1987) Diffuse Lewy body disease. Acta Neuropathol 75: 8-15
9. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S-H (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease. Neurol 41: 1402-1405
10. Durkin T, Galey D, Micheau J, Beslon H, Jaffard R (1986) The effects of intraseptal injection of haloperidol in vivo on hippocampal cholinergic function in the mouse. Brain Res 376: 420-424
11. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) The influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 145: 1472-1484
12. Levin ED, McGurk SR, Rose JE, Butcher LL (1990) Cholinergic-dopaminergic.interactions in cognitive performance. Behav Neural Biol 54: 271-299
13. Levy R, Eagger S, Griffiths M, Perry EK, Honavar M, Dean A, Lantos P (1994) Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 343: 176
14. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992a) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22: 911-922
15. McKeith IG, Fairbairn AF, Perry R, Thompson P, Perry EK (1992b) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 305: 673-678
16. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH (1994) An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872-877
17. McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT) - do the diagnostic systems for dementia need to be revised? Br J Psychiatry 165: 324-332
18. Perry EK (1997) Cholinergic phytochemicals: from magic to medicine. Aging & Mental Health 1: 23-32
19. Perry EK, Perry RH (1995) Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn
20. Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE (1977) A cholinergic connection between normal ageing and senile dementia of the human hippocampus. Neurosci Lett 6: 85-89
21. Perry EK, Marshall E, Kerwin JM, Smith CJ, Jabeen S, Cheng AV, Perry RH (1990b) Evidence of a monoaminergic: cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 55(4): 1454-1456
22. Perry EK, Smith CJ, Court JA, Perry RH (1990c) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm [PD-Sect] 2: 149-158
23. Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, Perry RH (1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer's disease. Alz Dis Assoc Disord 7(2): 69-79
24. Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG, Perry RH (1994) Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport 5: 747-749
25. Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF (1989) Clinically and neuropathologically distinct form of dementia in the elderly. Lancet i: 166
26. Perry RH, Irving D, Blessed G, Fairbairn AF, Perry EK (1990a) A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119-139
27. 2 receptors in demented patients with severe neuroleptic sensitivity. Lancet 343: 1044-1045
28. Sahgal A, Galloway PG, McKeith IG, Edwardson JA, Lloyd S (1992a) A comparative study of attentional deficits in senile dementia of Alzheimer and Lewy body types. Dementia 3: 350-354
29. Sawle GV (1995) Living neurochemistry: the dopamine system. The Neurosciences 7: 173-177
30. Shergill S, Mullan E, D'Ath P, Katona C (1994) What is the clinical prevalence of Lewy body dementia? Int J Geriatr Psychiatry 9: 907-912
31. Wilcock GK, Scott MI (1994) Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet 344: 544
32. Woodard (1962) Concentric hyaline inclusion body formation in mental disease: analysis of twenty seven cases. J Neuropathol Exp Neurol 21: 442-449
33. Zorn SH, Jones SB, Ward KM, Liston DR (1994) Clozapine is a potent and selective muscarinic m4 receptor agonist. Eur J Mol Pharmacol 264: R1-R2